Ipca launches new topical therapy against diabetic foot ulcer

Ipca Laboratories introduced Diulcus, a topical gel designed to treat diabetic foot ulcers, priced at Rs 1365 per pack. The gel is based on repurposed beta blocker Esmolol. Approved after clinical trials, the product showed promising ulcer closure rates, with Ipca targeting a substantial market share within three years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uZ9mpIs
via IFTTT